Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

H. Gill · SciRah

Researcher profile · Semantic Scholar

H. Gill

Share profile

H. Gill — researcher profile on SciRah

h-index: 22
Works: 118
Citations: 2,049

Most-cited papers

Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study.
W. Seto, ThomasSau-Yan Chan, Y. Hwang, D. Wong +8 more
2014Journal of Clinical Oncology301 citations
Semantic Scholar
Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: A prospective study
W. Seto, T. Chan, Y. Hwang, D. Wong +10 more
2017Hepatology102 citations Open access
Semantic Scholar
Disseminated Infections with Talaromyces marneffei in Non-AIDS Patients Given Monoclonal Antibodies against CD20 and Kinase Inhibitors
J. Chan, T. Chan, H. Gill, Frank Y.F. Lam +7 more
2015Emerging Infectious Diseases74 citations Open access
Semantic Scholar
Homoharringtonine (omacetaxine mepesuccinate) as an adjunct for FLT3-ITD acute myeloid leukemia
Stephen S. Y. Lam, E. Ho, Bai-Liang He, W. Wong +16 more
2016Science Translational Medicine73 citations
Semantic Scholar
Association of Hepatitis B Core-Related Antigen With Hepatitis B Virus Reactivation in Occult Viral Carriers Undergoing High-Risk Immunosuppressive Therapy
W. Seto, D. Wong, ThomasSau-Yan Chan, Y. Hwang +9 more
2016American Journal of Gastroenterology73 citations
Semantic Scholar
Long‐term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide‐based reinduction and maintenance regimens: A 15‐year prospective study
H. Gill, Rita Yim, Harold-Kwok Lee, V. Mak +12 more
2018Cancer54 citations Open access
Semantic Scholar
Molecular and Cellular Mechanisms of Myelodysplastic Syndrome: Implications on Targeted Therapy
H. Gill, A. H. Leung, Yok-Lam Kwong
2016International Journal of Molecular Sciences50 citations Open access
Semantic Scholar
A novel tescalcin-sodium/hydrogen exchange axis underlying sorafenib resistance in FLT3-ITD+ AML.
C. Man, Stephen S Y Lam, M. K. Sun, Howard C. H. Chow +3 more
2013Blood43 citations
Semantic Scholar
SURPASS-ET: phase III study of ropeginterferon alfa-2b versus anagrelide as second-line therapy in essential thrombocythemia.
S. Verstovsek, N. Komatsu, H. Gill, Jie Jin +9 more
2022Future Oncology39 citations Open access
Semantic Scholar
Next-generation sequencing with a myeloid gene panel in core-binding factor AML showed KIT activation loop and TET2 mutations predictive of outcome
C. Y. Cher, G. Leung, Chun-Hang Au, T. Chan +19 more
2016Blood Cancer Journal36 citations Open access
Semantic Scholar
Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021
H. Gill, R. Raghupathy, C. Lee, Yammy Yung +14 more
2023BMC Cancer35 citations Open access
Semantic Scholar
Characteristics and predictors of early hospital deaths in newly diagnosed APL: a 13-year population-wide study.
H. Gill, Yammy Yung, H. Chu, Wing-Yan Au +10 more
2021Blood Advances35 citations Open access
Semantic Scholar
The thrombopoietin mimetics eltrombopag and romiplostim in the treatment of refractory aplastic anaemia
H. Gill, G. Leung, D. Lopes, Yok-Lam Kwong
2017British Journal of Haematology34 citations
Semantic Scholar
Molecular Targeted Therapy and Immunotherapy for Myelodysplastic Syndrome
Paul Lee, Rita Yim, Yammy Yung, H. Chu +2 more
2021International Journal of Molecular Sciences33 citations Open access
Semantic Scholar
From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag
H. Gill, R. Wong, Yok-Lam Kwong
2017Therapeutic Advances in Hematology33 citations Open access
Semantic Scholar
Eltrombopag in the management of aplastic anaemia: real-world experience in a non-trial setting
Y. Hwang, H. Gill, T. Chan, G. Leung +2 more
2018Hematology29 citations Open access
Semantic Scholar
Oral arsenic trioxide incorporation into frontline treatment with all‐trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5‐year prospective study
H. Gill, C. Kumana, Rita Yim, Y. Hwang +15 more
2019Cancer27 citations Open access
Semantic Scholar
Risk of viral reactivation in patients with occult hepatitis B virus infection during ruxolitinib treatment
H. Gill, G. Leung, W. Seto, Yok-Lam Kwong
2018Annals of Hematology24 citations
Semantic Scholar
Breakthrough invasive fungal diseases during echinocandin treatment in high-risk hospitalized hematologic patients
T. Chan, H. Gill, Y. Hwang, J. Sim +8 more
2014Annals of Hematology23 citations
Semantic Scholar
Supportive care and symptom management in patients with advanced hematological malignancies: a literature review.
Kwok-Ying Chan, T. Chan, H. Gill, T. Chan +11 more
2022Annals of Palliative Medicine22 citations Open access
Semantic Scholar
A Phase 2 Study of the LSD1 Inhibitor Img-7289 (bomedemstat) for the Treatment of Advanced Myelofibrosis
H. Gill, A. Yacoub, K. Pettit, T. Bradley +21 more
2021Blood22 citations Open access
Semantic Scholar
Resurrection of Oral Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: A Historical Account From Bedside to Bench to Bedside
C. Kumana, R. Mak, Yok-Lam Kwong, H. Gill
2020Frontiers in Oncology22 citations Open access
Semantic Scholar
Oral arsenic trioxide, all‐trans retinoic acid, and ascorbic acid maintenance after first complete remission in acute promyelocytic leukemia: Long‐term results and unique prognostic indicators
H. Gill, Rita Yim, C. Kumana, E. Tse +1 more
2020Cancer21 citations Open access
Semantic Scholar
Cytomegalovirus retinitis complicating combination therapy with rituximab and fludarabine
T. Chan, Carol Y. M. Cheung, I. Yeung, Y. Hwang +3 more
2015Annals of Hematology21 citations
Semantic Scholar
Valganciclovir suppressed Epstein Barr virus reactivation during immunosuppression with alemtuzumab.
H. Gill, Y. Hwang, T. Chan, A. Pang +3 more
2014Journal of Clinical Virology20 citations
Semantic Scholar
Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms
Yammy Yung, Emily Lee, H. Chu, Pui-Kwan Yip +1 more
2021International Journal of Molecular Sciences19 citations Open access
Semantic Scholar
Next-generation sequencing with a 54-gene panel identified unique mutational profile and prognostic markers in Chinese patients with myelofibrosis
H. Gill, Ho-Wan Ip, Rita Yim, Wing F. Tang +11 more
2018Annals of Hematology18 citations
Semantic Scholar
Targeting and Monitoring Acute Myeloid Leukaemia with Nucleophosmin-1 (NPM1) Mutation
Lynn Chin, C. Wong, H. Gill
2023International Journal of Molecular Sciences17 citations Open access
Semantic Scholar
Primary treatment of leukemia relapses after allogeneic hematopoietic stem cell transplantation with reduced‐intensity conditioning second transplantation from the original donor
A. H. Leung, E. Tse, Y. Hwang, T. Chan +4 more
2013American journal of hematology/oncology17 citations
Semantic Scholar
Myeloproliferative neoplasms treated with hydroxyurea, pegylated interferon alpha-2A or ruxolitinib: clinicohematologic responses, quality-of-life changes and safety in the real-world setting
H. Gill, G. Leung, Rita Yim, Paul Lee +7 more
2020Hematology16 citations Open access
Semantic Scholar
Molecularly targeted therapy in acute myeloid leukemia.
H. Gill, A. H. Leung, Yok-Lam Kwong
2016Future Oncology16 citations
Semantic Scholar
Early integrated palliative care for haematology cancer patients-the impact on symptom burden in Hong Kong.
Kwok-Ying Chan, H. Gill, T. Chan, Cho-Wing Li +4 more
2021Annals of Palliative Medicine15 citations Open access
Semantic Scholar
Torsade de Pointes during oral arsenic trioxide therapy for acute promyelocytic leukemia in a patient with heart failure
J. Hai, H. Gill, H. Tse, C. Kumana +2 more
2015Annals of Hematology15 citations
Semantic Scholar
The Development and Clinical Applications of Oral Arsenic Trioxide for Acute Promyelocytic Leukaemia and Other Diseases
Lynn Chin, C. Kumana, Yok-Lam Kwong, H. Gill
2022Pharmaceutics14 citations Open access
Semantic Scholar
Delayed Nephrotoxicity After 225Ac-PSMA-617 Radioligand Therapy.
S. Satapathy, Amit Sharma, A. Sood, Pooja Maheshwari +1 more
2022Clinical Nuclear Medicine14 citations
Semantic Scholar
A Phase 2 Study of the LSD1 Inhibitor Bomedemstat (IMG-7289) for the Treatment of Advanced Myelofibrosis (MF): Updated Results and Genomic Analyses
K. Pettit, H. Gill, A. Yacoub, T. Bradley +28 more
2022Blood14 citations Open access
Semantic Scholar
Bomedemstat as an investigative treatment for myeloproliferative neoplasms
H. Rienhoff, H. Gill
2023Expert Opinion on Investigational Drugs13 citations
Semantic Scholar
A Phase 2 Study of the LSD1 Inhibitor Bomedemstat (IMG-7289) for the Treatment of Essential Thrombocythemia (ET)
H. Gill, F. Palandri, D. Ross, T. Cochrane +21 more
2022Blood13 citations Open access
Semantic Scholar
Azacitidine as post-remission consolidation for sorafenib-induced remission of Fms-like tyrosine kinase-3 internal tandem duplication positive acute myeloid leukemia
H. Gill, C. Man, Alvin H. W. Ip, W. Choi +3 more
2015Haematologica13 citations Open access
Semantic Scholar
Oral arsenic trioxide-based regimen as salvage treatment for relapsed or refractory mantle cell lymphoma.
H. Gill, W.-Y. Au, Winnie W. W. Cheung, E. Lee +1 more
2013Annals of Oncology13 citations Open access
Semantic Scholar
Lysine-Specific Demethylase 1 (LSD1/KDM1A) Inhibition as a Target for Disease Modification in Myelofibrosis
H. Gill
2022Cells12 citations Open access
Semantic Scholar
Bomedemstat (IMG-7289), an LSD1 Inhibitor, Manages the Signs and Symptoms of Essential Thrombocythemia (ET) While Reducing the Burden of Cells Homozygous for Driver Mutations
J. Goethert, H. Gill, F. Palandri, David M. Ross +16 more
2023Blood11 citations Open access
Semantic Scholar
Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation
H. Gill, Rita Yim, H. Pang, Paul Lee +21 more
2020Cancer Medicine11 citations Open access
Semantic Scholar
Phase 2 Study to Assess the Safety and Efficacy of Bomedemstat (MK3543) in Combination with Ruxolitinib in Patients with Myelofibrosis
H. Gill, Lester Au, G. Leung, Dorothy Tsai +8 more
2023Blood10 citations Open access
Semantic Scholar
Ropeginterferon Alfa-2b for Pre-Fibrotic Primary Myelofibrosis and DIPSS Low/Intermediate-1 Risk Myelofibrosis: Durable Responses and Evidence of Disease Modification
H. Gill, Lester Au, G. Leung, Dorothy Tsai +8 more
2023Blood9 citations Open access
Semantic Scholar
Posaconazole vs fluconazole or itraconazole for prevention of invasive fungal diseases in patients with acute myeloid leukemia or myelodysplastic syndrome: a cost-effectiveness analysis in an Asian teaching hospital
T. Chan, S. Marcella, H. Gill, Y. Hwang +1 more
2016Journal of Medical Economics9 citations Open access
Semantic Scholar
Safety and Preliminary Efficacy of DFV890 in Adult Patients with Myeloid Diseases: A Phase 1b Study
G. Garcia-Manero, Melissa G. Ooi, Z. Lao, H. Gill +10 more
2023Blood7 citations Open access
Semantic Scholar
Oral arsenic trioxide for treating acute promyelocytic leukaemia: Implications for its worldwide epidemiology and beyond
C. Kumana, Yok-Lam Kwong, H. Gill
2022Frontiers in Oncology7 citations Open access
Semantic Scholar
FLT3 internal tandem duplication in acute promyelocytic leukemia: central nervous system relapse
H. Gill, Ho-Wan Ip, A. Pang, J. Sum +2 more
2015Annals of Hematology6 citations
Semantic Scholar
Evolving landscape of JAK inhibition in myelofibrosis: monotherapy and combinations.
H. Gill, Garret M. K. Leung, Yok-Lam Kwong
2023Hematology. American Society of Hematology. Education Program5 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Yok-Lam Kwong×34
Invite
Yok-Lam Kwong — researcher profile on SciRah
T. Chan×13
Invite
T. Chan — researcher profile on SciRah
Y. Hwang×12
Invite
Y. Hwang — researcher profile on SciRah
Rita Yim×11
Invite
Rita Yim — researcher profile on SciRah

×9

Invite

C. Kumana — researcher profile on SciRah

Invite

G. Leung — researcher profile on SciRah

Invite

A. Lie — researcher profile on SciRah

Invite

Ho-Wan Ip — researcher profile on SciRah

Edmond S. K. Ma×6

Invite

Edmond S. K. Ma — researcher profile on SciRah

Invite

A. H. Leung — researcher profile on SciRah

Invite

R. Leung — researcher profile on SciRah

Invite

E. Tse — researcher profile on SciRah